Need Help? Call 1­-866-­796-­7386
« back to stock screener

  DRNA stock: Dicerna Pharmaceuticals Inc

Current Rating
Hold/Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$13.79
Market Cap
964.6M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
4.62
P/S
150.28
Dividend %
-
P/CF
-
P/FCF
100.7
Op. Cash Flow
18.3K
FCF
0.1
Op. Margin
-
Net Margin
-
ROE
-69.80%
ROI
-45.00%
ROA
-45.10%
EPS Growth
55.80%
Current Ratio
4.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Cumberland Pharmaceuticals, In (CPIX) $5.82 - - 88.1M Strong Buy
BioScrip Inc (BIOS) $1.71 - - 232M Strong Buy
Lannett Company, Inc. (LCI) $7.15 - - 297M Strong Buy
Cryolife Inc (CRY) $27.55 - - 1.05B Strong Buy
Bausch Health Companies Inc (BHC) $23.13 - - 8.6B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More